Long-term evolution of multiple sclerosis disability in the treatment era

The outcome spectrum of multiple sclerosis: disability, mortality, and a cluster of predictors from onset

(2015) Helen Tedeholm et al.   JOURNAL OF NEUROLOGY

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis

(2015) Regina Schlaeger et al.   JAMA Neurology

Evaluation of No Evidence of Disease Activity in a 7-Year Longitudinal Multiple Sclerosis Cohort

(2015) Dalia L. Rotstein et al.   JAMA Neurology

Spinal cord gray matter atrophy correlates with multiple sclerosis disability

(2014) Regina Schlaeger et al.   ANNALS OF NEUROLOGY

Safety and efficacy of fingolimod in patients with relapsing-remitting multiple sclerosis (FREEDOMS II): a double-blind, randomised, placebo-controlled, phase 3 trial

(2014) Peter A Calabresi et al.   LANCET NEUROLOGY

Defining the clinical course of multiple sclerosis: The 2013 revisions

(2014) F. D. Lublin et al.   NEUROLOGY

Estimating Typical Multiple Sclerosis Disability Progression Speed from Clinical Observations

(2014) Murray G. Brown et al.   PLoS One

Azathioprine versus Beta Interferons for Relapsing-Remitting Multiple Sclerosis: A Multicentre Randomized Non-Inferiority Trial

(2014) Luca Massacesi et al.   PLoS One

Vitamin D as an Early Predictor of Multiple Sclerosis Activity and Progression

(2014) Alberto Ascherio et al.   JAMA Neurology

Disease Activity Free Status

(2014) Carolyn J. Bevan et al.   JAMA Neurology

Teriflunomide in the treatment of multiple sclerosis: current evidence and future prospects

(2014) Jiwon Oh et al.   Therapeutic Advances in Neurological Disorders

Randomized study combining interferon and glatiramer acetate in multiple sclerosis

(2013) Fred D. Lublin et al.   ANNALS OF NEUROLOGY

Clinical and MRI predictors of response to interferon-beta and glatiramer acetate in relapsing-remitting multiple sclerosis patients

(2013) M. Romeo et al.   EUROPEAN JOURNAL OF NEUROLOGY

Blood RNA profiling in a large cohort of multiple sclerosis patients and healthy controls

(2013) Dorothee Nickles et al.   HUMAN MOLECULAR GENETICS

Mycophenolate mofetil in multiple sclerosis: a multicentre retrospective study on 344 patients

(2013) L. Michel et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Vitamin D status predicts new brain magnetic resonance imaging activity in multiple sclerosis

(2012) Ellen M. Mowry et al.   ANNALS OF NEUROLOGY

Predictors of long-term outcome in multiple sclerosis patients treated with interferon beta

(2012) Robert A. Bermel et al.   ANNALS OF NEUROLOGY

Progressive multiple sclerosis: pathology and pathogenesis

(2012) Hans Lassmann et al.   Nature Reviews Neurology

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Relationship between early clinical characteristics and long term disability outcomes: 16 year cohort study (follow-up) of the pivotal interferon β-1b trial in multiple sclerosis

(2011) Douglas S Goodin et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial

(2011) Ludwig Kappos et al.   LANCET

Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis

(2011) Stephen Sawcer et al.   NATURE

Vitamin D in African Americans with multiple sclerosis

(2011) J. M. Gelfand et al.   NEUROLOGY

Switching Multiple Sclerosis Patients with Breakthrough Disease to Second-Line Therapy

(2011) Tamara Castillo-Trivino et al.   PLoS One

Aggregation of multiple sclerosis genetic risk variants in multiple and single case families

(2010) Pierre-Antoine Gourraud et al.   ANNALS OF NEUROLOGY

One-year MRI scan predicts clinical response to interferon beta in multiple sclerosis

(2009) L. Prosperini et al.   EUROPEAN JOURNAL OF NEUROLOGY

Earlier disability of the patients followed in Multiple Sclerosis centers compared to outpatients

(2009) M Debouverie et al.   Multiple Sclerosis Journal

Natural history of multiple sclerosis in a population-based cohort

(2008) M. Debouverie et al.   EUROPEAN JOURNAL OF NEUROLOGY

Variations in functioning and disability in multiple sclerosis

(2008) C. Ytterberg et al.   JOURNAL OF NEUROLOGY

Gray matter atrophy correlates with MS disability progression measured with MSFC but not EDSS

(2008) Richard A. Rudick et al.   JOURNAL OF THE NEUROLOGICAL SCIENCES

Glatiramer acetate after induction therapy with mitoxantrone in relapsing multiple sclerosis

(2008) T Vollmer et al.   Multiple Sclerosis Journal

Natural history of secondary-progressive multiple sclerosis

(2008) Helen Tremlett et al.   Multiple Sclerosis Journal

Disability as an outcome in MS clinical trials

(2008) G. C. Ebers et al.   NEUROLOGY

MRI as an outcome in multiple sclerosis clinical trials

(2008) M. Daumer et al.   NEUROLOGY